Blake Byers

Investment Stage

Focus Areas

About Investor

Blake Byers is a scientist, entrepreneur, and investor who spent many years investing at GV. After leaving GV, he continued investing through his own platform and became involved in biotechnology entrepreneurship, including NewLimit. His background is unusually broad across life sciences, biotech, software, deep technology, and company creation. Their experience is particularly relevant to founders operating in healthcare, digital health, medical technology, and technology-enabled care delivery. They understand that healthcare companies must balance product innovation with clinical credibility, trust, operational execution, and complex market structures. Their background can help teams think through commercialization, partnerships, adoption, scaling, and the practical requirements of building in regulated or high-stakes environments. For founders, this perspective can be especially useful when translating a compelling healthcare innovation into a trusted and repeatable business.